The new institution will represent and give visibility to young scientists, preferably from the field of experimental sciences
Personal chronicle of the day by Tanya Yates
Although the event itself is not due to start till 10 am, at 7 am a small group of sleepy people from the Communications Department (including me) are already busy with the logistics of the event. Bit by bit, our eager “crazies” (different generations of our Crazy About Biomedicine programme for secondary school students) start to arrive, PhD students turn up to organise the multiple stands in the Science Fair, admin staff take up duties at the registration desk… it’s 10 am. I love punctuality!
People start to trickle down the street. It’s...
It is estimated that one in four people will require brain treatment at some point. While there are drug candidates for most diseases of the brain, the blood-brain barrier (BBB) poses an impassable obstacle for most of these compounds and a bottleneck for the delivery of drugs that could cure these patients.
In the Peptides and Proteins Lab at the Institute for Research in Biomedicine (IRB Barcelona), Dr. Meritxell Teixidó headsa line of research that, after 10 years, has led to the development of a technology called Gate2Brain. This patented technology consists of three...
Ona Therapeutics, a spin-off from IRB Barcelona and ICREA, has been founded by researchers Salvador Aznar-Benitah and Valerie Vanhooren after receiving investment from Sabadell Asabys.
Based at the Barcelona Science Park, the company focuses on the development of a new drug for the treatment of metastatic cancer.
The Sabadell Asabys Fund, which belongs to Asabys Partners, has invested € 1.5M into the company in order to start a venture round that could reach € 20M.
Academia Programme run by ICREA seeks to foster research excellence among professors at public universities in Catalonia.
Scientists from all over the world gathered in Barcelona to analyze the development of cancer in Drosophila, the fruit fly whose characteristics accelerate the study of the disease.
Through the campaign called #MetastasisChallenge, the centre aims to raise €5 M over the next four years.
Metastasis is responsible for 90% of deaths from cancer, and this campaign aims to rally social support for research in order to speed up discoveries.
It’s a joint initiative of IRB Barcelona, the Barcelona Supercomputing Center and the Centre for Genomic Regulation.
“StarLife” is funded by the Catalan Government, through the European Regional Development Fund, and by ”la Caixa”.
The Pfizer Foundation has awarded the IRB Barcelona scientist a prize within the “Basic Research” category.
Gloria Pascual, a member of the Stem Cells and Cancer lab, will receive €10,000 to continue her research
The Barcelona Institute of Science and Technology (BIST) will be bringing together 100 female researchers and technologists in a training and networking session next Thursday, 7 February, at the Barcelona Science Park. IRB Barcelona will be participating in this event.
The gathering is devoted to the preparation of the talks that the scientists will be giving around Catalonia on the International Day of Women and Girls in Science (11 February) and to ‘fostering a sense of community’ to reinforce the role of women as scientific and social leaders.
The mayor of Barcelona, Ada Colau, will be opening the event, which forms part of the Biennial City and Science Programme.